The Solidarity Trial was launched by WHO and international partners to accelerate COVID-19 treatment research.
It aimed to evaluate multiple antiviral and therapeutic agents across different countries in a large-scale clinical study.
This initiative streamlined data collection and analysis to improve treatment strategies globally.